25 related articles for article (PubMed ID: 19713108)
1. Synthesis of portimines reveals the basis of their anti-cancer activity.
Tang J; Li W; Chiu TY; Martínez-Peña F; Luo Z; Chong CT; Wei Q; Gazaniga N; West TJ; See YY; Lairson LL; Parker CG; Baran PS
Nature; 2023 Oct; 622(7983):507-513. PubMed ID: 37730997
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of amantadine clubbed
Zahra FT; Saeed A; Ahmed A; Ismail H; Ijaz MU; Albericio F
RSC Adv; 2023 Aug; 13(36):24988-25001. PubMed ID: 37614781
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization and biological evaluation of Pd(ii), Cu(ii), Re(i) and
Mašković JM; Hatzidimitriou A; Damjanović A; Stanojković TP; Trifunović SR; Geronikaki AA; Papagiannopoulou D
Medchemcomm; 2018 May; 9(5):831-842. PubMed ID: 30108972
[TBL] [Abstract][Full Text] [Related]
4. Tubulin inhibitors: pharmacophore modeling, virtual screening and molecular docking.
Niu MM; Qin JY; Tian CP; Yan XF; Dong FG; Cheng ZQ; Fida G; Yang M; Chen HY; Gu YQ
Acta Pharmacol Sin; 2014 Jul; 35(7):967-79. PubMed ID: 24909516
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterization and antimicrobial activity of certain novel aryl hydrazone pyrazoline-5-ones containing thiazole moiety.
Reddy MR; Prasad AR; Spoorthy YN; Ravindranath LR
Adv Pharm Bull; 2013; 3(1):153-9. PubMed ID: 24312829
[TBL] [Abstract][Full Text] [Related]
6. Stereocontrolled routes to beta,beta'-disubstituted alpha-amino acids.
Michaux J; Niel G; Campagne JM
Chem Soc Rev; 2009 Jul; 38(7):2093-116. PubMed ID: 19551183
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization, and cytotoxicity of some novel glycosyl thiazol-2-imines as antitumoral agents.
Zhao Q; Shen C; Zheng H; Zhang J; Zhang P
Carbohydr Res; 2010 Feb; 345(3):437-41. PubMed ID: 20035929
[TBL] [Abstract][Full Text] [Related]
8. One pot synthesis of thiazolodihydropyrimidinones and evaluation of their anticancer activity.
Holla BS; Rao BS; Sarojini BK; Akberali PM
Eur J Med Chem; 2004 Sep; 39(9):777-83. PubMed ID: 15337290
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro evaluation of the anticancer activity of novel fluorinated thiazolo[4, 5-d]pyrimidines.
Fahmy HT; Rostom SA; Saudi MN; Zjawiony JK; Robins DJ
Arch Pharm (Weinheim); 2003 Jul; 336(4-5):216-25. PubMed ID: 12916055
[TBL] [Abstract][Full Text] [Related]
10. Stereoselective synthesis of beta-lactams with polyaromatic imines: entry to new and novel anticancer agents.
Banik I; Becker FF; Banik BK
J Med Chem; 2003 Jan; 46(1):12-5. PubMed ID: 12502355
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antiproliferative activity of 2-aryl-4-oxo-thiazolidin-3-yl-amides for prostate cancer.
Gududuru V; Hurh E; Dalton JT; Miller DD
Bioorg Med Chem Lett; 2004 Nov; 14(21):5289-93. PubMed ID: 15454213
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and anticancer activity of novel 3,4-diarylthiazol-2(3H)-ones (imines).
Liu ZY; Wang YM; Li ZR; Jiang JD; Boykin DW
Bioorg Med Chem Lett; 2009 Oct; 19(19):5661-4. PubMed ID: 19713108
[TBL] [Abstract][Full Text] [Related]
13. Impact of natural products on developing new anti-cancer agents.
Cragg GM; Grothaus PG; Newman DJ
Chem Rev; 2009 Jul; 109(7):3012-43. PubMed ID: 19422222
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
